Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Invitae | RCV001047544 | SCV001211509 | uncertain significance | Hereditary hemorrhagic telangiectasia | 2022-02-03 | criteria provided, single submitter | clinical testing | In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is not expected to disrupt ENG protein function. ClinVar contains an entry for this variant (Variation ID: 844639). This variant has not been reported in the literature in individuals affected with ENG-related conditions. This variant is not present in population databases (gnomAD no frequency). This sequence change replaces arginine, which is basic and polar, with lysine, which is basic and polar, at codon 39 of the ENG protein (p.Arg39Lys). |
Institute of Human Genetics, |
RCV002287462 | SCV002577833 | uncertain significance | Interstitial pneumonitis | 2021-12-21 | criteria provided, single submitter | clinical testing | ACMG categories: PM2,PM5,BP4 |
Fulgent Genetics, |
RCV002505585 | SCV002815593 | uncertain significance | Telangiectasia, hereditary hemorrhagic, type 1 | 2021-12-29 | criteria provided, single submitter | clinical testing |